Plus Therapeutics (PSTV) Expected to Release Quarterly Earnings on Thursday
Plus Therapeutics (NASDAQ:PSTV – Get Free Report) is projected to post its Q2 2026 results after the market closes on Thursday, August 13th. Analysts expect Plus Therapeutics to post earnings of ($0.88) per share and revenue of $1.1130 million for the quarter. Individuals may visit the the company’s upcoming Q2 2026 earning overview page for […]
12 Aug 06:10 · The Markets Daily